United Kingdom · 
Who invested in Ascend Gene & Cell Therapies?
Ascend Gene & Cell Therapies's investors include DCVC, LD Capital, Deerfield and Digitalis Ventures.
United Kingdom · Series A startup
Who invested in Ascend Gene & Cell Therapies
One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$66Mraised across 1 round since 2023, from 2 sources
- Latest round
- Series A, $66MMar 2023
- Investors
- 4
The rounds
- Mar 2023Series A$66M
Source recorded and 1 otherSEC filing: $67M sold, first sale Feb 2023
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Ascend Gene & Cell Therapies
How much has Ascend Gene & Cell Therapies raised?
Ascend Gene & Cell Therapies has raised $66M across 1 round since 2023.
When did Ascend Gene & Cell Therapies last raise?
Ascend Gene & Cell Therapies's most recent round was a Series A of $66M in Mar 2023.
What was Ascend Gene & Cell Therapies's biggest round?
Its most recent round, $66M in Mar 2023, is also its largest on record.
Who backed Ascend Gene & Cell Therapies first?
Ascend Gene & Cell Therapies's first round on record, in Mar 2023, was backed by DCVC, LD Capital and Deerfield and 1 others.
What stage is Ascend Gene & Cell Therapies at?
Ascend Gene & Cell Therapies's latest named round is a Series A, in Mar 2023.
Where is Ascend Gene & Cell Therapies based?
Ascend Gene & Cell Therapies is based in the United Kingdom.
Companies like Ascend Gene & Cell Therapies
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.